Bixiye
QP93-19 Provider Cost Data Update
Taariikhda uu dhaqangalayo Barnaamijka: Nov 27, 2019
Natiijooyinka Raadinta
Soo bandhiga 2551 - 2560 ee natiijooyinka 3698
Bixiye
QP99-19 Pharmacy Benefit Exclusion for Rapatha ®
Taariikhda uu dhaqangalayo Barnaamijka: Nov 27, 2019
Bixiye
QP96-19 Pharmacy Benefit Exclusion for PolivyTM, KanjintiTM, Evenity ®, BelrapzoTM, MvasiTM, Clinolipid 20%, Cisplatin, Heparin Sodium, and Selenious acid
Taariikhda uu dhaqangalayo Barnaamijka: Nov 27, 2019
Bixiye
P7-20 Musculoskeletal Management Program Updates for Fully Insured Commercial and Medicare Advantage Subscribers – eviCore Healthcare Specialty Utilization Management (UM) Program
Taariikhda uu dhaqangalayo Barnaamijka: Jan 02, 2020
Bixiye
P5-20 Cardiology & Radiology Clinical Guideline Updates for Fully Insured Commercial and Medicare Advantage Subscribers – eviCore Healthcare Specialty Utilization Management (UM) Program
Taariikhda uu dhaqangalayo Barnaamijka: Jan 02, 2020
Bixiye
P86-19 Compliance with SAMSHA Part 2 Regulations and Identifying Claims Subject to Federal Confidentiality of Substance Use Disorder Regulations
Taariikhda uu dhaqangalayo Barnaamijka: Des 02, 2019
Bixiye
P88-19 Mental Health Adult and Child Crisis Services Billing
Taariikhda uu dhaqangalayo Barnaamijka: Des 02, 2019
Bixiye
P87-19 New Medical, Medical Drug and Behavioral Health Policy Management Updates- Effective January 6, 2020
Taariikhda uu dhaqangalayo Barnaamijka: Des 02, 2019
Bixiye
QP82R1-19 Pharmacy Benefit Update - $0 Insulin Member Cost-Share Benefit for Commercial Lines of Business
Taariikhda uu dhaqangalayo Barnaamijka: Nov 27, 2019